AEGON ASSET MANAGEMENT UK Plc Increases Stock Holdings in Danaher Corporation $DHR

Key Points

• AEGON ASSET MANAGEMENT UK Plc has increased its holdings in Danaher Corporation by 5.5% during the second quarter, now owning a total of 152,837 shares valued at approximately $30.2 million.
• Institutional investors now hold 79.05% of Danaher's stock, with several firms, including GHP Investment Advisors Inc. and Sierra Ocean LLC, significantly increasing their stakes.
• Danaher recently posted $1.80 EPS for the last quarter, surpassing expectations, and announced a quarterly dividend of $0.32 per share to be paid on October 31st.

AEGON ASSET MANAGEMENT UK Plc increased its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 5.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 152,837 shares of the conglomerate's stock after acquiring an additional 7,996 shares during the quarter. AEGON ASSET MANAGEMENT UK Plc's holdings in Danaher were worth $30,179,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. GHP Investment Advisors Inc. raised its holdings in Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after purchasing an additional 99 shares in the last quarter. Sierra Ocean LLC raised its holdings in Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after purchasing an additional 76 shares in the last quarter. Red Tortoise LLC raised its holdings in Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate's stock worth $30,000 after purchasing an additional 98 shares in the last quarter. Smallwood Wealth Investment Management LLC bought a new position in Danaher in the first quarter worth $31,000. Finally, Dunhill Financial LLC raised its holdings in Danaher by 68.4% in the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after purchasing an additional 67 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of research reports. Bank of America decreased their price objective on Danaher from $230.00 to $220.00 and set a "buy" rating for the company in a report on Monday, September 22nd. Evercore ISI increased their price objective on Danaher from $226.00 to $245.00 and gave the stock an "outperform" rating in a report on Tuesday, October 7th. Redburn Partners set a $220.00 price objective on Danaher in a report on Wednesday, October 8th. Guggenheim restated a "buy" rating and set a $250.00 price target on shares of Danaher in a report on Wednesday, July 23rd. Finally, Rothschild & Co Redburn restated a "neutral" rating and set a $220.00 price target (down from $245.00) on shares of Danaher in a report on Wednesday, October 8th. Seventeen analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, Danaher presently has a consensus rating of "Moderate Buy" and a consensus target price of $244.60.

Danaher Price Performance

Shares of NYSE:DHR opened at $206.19 on Wednesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.41. The company has a market capitalization of $147.64 billion, a PE ratio of 43.87, a PEG ratio of 2.92 and a beta of 0.77. The business has a fifty day moving average price of $200.96 and a 200-day moving average price of $197.13.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company had revenue of $5.94 billion for the quarter, compared to analysts' expectations of $5.83 billion. During the same period last year, the firm posted $1.72 earnings per share. Danaher's revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher's dividend payout ratio (DPR) is 27.23%.

Insider Activity at Danaher

In related news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director directly owned 20,751 shares of the company's stock, valued at $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 11.20% of the stock is owned by company insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.